Malignant Neoplasm of Stomach Completed Phase 2 Trials for Cetuximab (DB00002)

Also known as: Gastric Cancers / Stomach Cancer / Gastric cancer / Gastric Malignancies / Gastric cancer NOS / Cancer of Stomach / Malignant neoplasm of stomach, unspecified / Gastric malignancy

IndicationStatusPhase
DBCOND0045917 (Malignant Neoplasm of Stomach)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00857246Pre-operation Chemo and Antibody Therapy Followed by Surgical Resection and Adjuvant Chemoradiation for Gastric CancerTreatment
NCT00130689Use of Cetuximab for Unresectable or Metastatic Esophageal and Gastric CancerTreatment
NCT00397904Cetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and CisplatinTreatment
NCT00398398Study of XELOX With Cetuximab in Advanced Gastric CancerTreatment
NCT00477711A Study of Cetuximab(Erbitux) With Cisplatin and Capecitabine(Xeloda)as 1st Line Treatment in the Advanced Gastric CancerTreatment
NCT00699881Study of Cetuximab to Treat Gastric CancerTreatment
NCT01360086Fluorouracil, Cisplatin, Leucovorin Calcium, and Cetuximab in Treating Patients With Adenocarcinoma of the Stomach or Gastroesophageal JunctionTreatment
NCT01388790Cetuximab in Combination With S-1 and Cisplatin in Gastric CancerTreatment
NCT01904435Cetuximab, Paclitaxel, Carboplatin And Radiation For Esophageal, Gastroesophageal Junction And Gastric CancerTreatment